Plasma-Cell Dyscrasia after Alkylating-Agent Therapy for Hodgkin's Disease

Edward P. Gelmann, Lewis Hilliard Dennis

Research output: Contribution to journalLetterpeer-review

3 Scopus citations

Abstract

To the Editor: Second neoplasms induced by chemotherapy with alkylating agents are being seen with increasing frequency, especially in patients who have been successfully treated for Hodgkin's disease. Most notable has been the marked increase in acute nonlymphocytic leukemia over the expected incidence in this group.1 2 3 4 We report here the case of a patient, successfully treated with alkylating agents for Hodgkin's disease, who had a clonal malignant process of plasmacytic origin. A white woman first had right cervical lymphadenopathy in November 1971 at the age of 19. A lymph-node biopsy, a standard radiologic evaluation, and a bone-marrow biopsy disclosed that.

Original languageEnglish (US)
Pages (from-to)1350
Number of pages1
JournalNew England Journal of Medicine
Volume305
Issue number22
DOIs
StatePublished - Nov 26 1981
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Plasma-Cell Dyscrasia after Alkylating-Agent Therapy for Hodgkin's Disease'. Together they form a unique fingerprint.

Cite this